Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis

Summary: The present meta-analysis aims to evaluate the impact of myosteatosis on overall survival (OS) and progression-free survival (PFS) in patients with pancreatic cancer (PC). A comprehensive literature search was conducted in the Medline, Web of Science, and Embase databases. The hazard ratio...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Zhang, Licheng Wei, Jiangguo Li, Yuexia Deng, Wei Xu, Dongkui Chen, Xing Li
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224025689
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850121643500765184
author Xin Zhang
Licheng Wei
Jiangguo Li
Yuexia Deng
Wei Xu
Dongkui Chen
Xing Li
author_facet Xin Zhang
Licheng Wei
Jiangguo Li
Yuexia Deng
Wei Xu
Dongkui Chen
Xing Li
author_sort Xin Zhang
collection DOAJ
description Summary: The present meta-analysis aims to evaluate the impact of myosteatosis on overall survival (OS) and progression-free survival (PFS) in patients with pancreatic cancer (PC). A comprehensive literature search was conducted in the Medline, Web of Science, and Embase databases. The hazard ratio (HR) and corresponding 95% confidence interval (CI) for the association between myosteatosis and survival outcomes were pooled using a random-effects model. A total of 14 studies were included. The pooled analysis demonstrated that myosteatosis was significantly associated to poorer OS (HR: 1.50, 95% CI: 1.35–1.67, p < 0.001; I2 = 0%). The subgroup analysis revealed consistent results across various study characteristics, including geographic regions, cancer stages, follow-up durations, and study quality. In addition, myosteatosis was associated to worse PFS (HR: 1.34, 95% CI: 1.15–1.57, p < 0.001; I2 = 34%). The present meta-analysis indicates that myosteatosis is associated to significantly worse OS and PFS in patients with PC.
format Article
id doaj-art-558952fd4bd6441c9d8d65d5a9d52bda
institution OA Journals
issn 2589-0042
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series iScience
spelling doaj-art-558952fd4bd6441c9d8d65d5a9d52bda2025-08-20T02:35:01ZengElsevieriScience2589-00422024-12-01271211134310.1016/j.isci.2024.111343Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysisXin Zhang0Licheng Wei1Jiangguo Li2Yuexia Deng3Wei Xu4Dongkui Chen5Xing Li6Department of Gastroenterology, The Fourth Hospital of Changsha, Changsha City, Hunan Province 410006, P.R. ChinaDepartment of Gastroenterology, The Fourth Hospital of Changsha, Changsha City, Hunan Province 410006, P.R. ChinaDepartment of Gastroenterology, The Fourth Hospital of Changsha, Changsha City, Hunan Province 410006, P.R. ChinaDepartment of Gastroenterology, The Fourth Hospital of Changsha, Changsha City, Hunan Province 410006, P.R. ChinaDepartment of Gastroenterology, The Fourth Hospital of Changsha, Changsha City, Hunan Province 410006, P.R. ChinaDepartment of Gastroenterology, The Fourth Hospital of Changsha, Changsha City, Hunan Province 410006, P.R. ChinaDepartment of Critical Care Medicine, Changsha Hospital of Traditional Chinese Medicine (Changsha No. 8 Hospital), Changsha City, Hunan Province 410100, P.R. China; Corresponding authorSummary: The present meta-analysis aims to evaluate the impact of myosteatosis on overall survival (OS) and progression-free survival (PFS) in patients with pancreatic cancer (PC). A comprehensive literature search was conducted in the Medline, Web of Science, and Embase databases. The hazard ratio (HR) and corresponding 95% confidence interval (CI) for the association between myosteatosis and survival outcomes were pooled using a random-effects model. A total of 14 studies were included. The pooled analysis demonstrated that myosteatosis was significantly associated to poorer OS (HR: 1.50, 95% CI: 1.35–1.67, p < 0.001; I2 = 0%). The subgroup analysis revealed consistent results across various study characteristics, including geographic regions, cancer stages, follow-up durations, and study quality. In addition, myosteatosis was associated to worse PFS (HR: 1.34, 95% CI: 1.15–1.57, p < 0.001; I2 = 34%). The present meta-analysis indicates that myosteatosis is associated to significantly worse OS and PFS in patients with PC.http://www.sciencedirect.com/science/article/pii/S2589004224025689Health sciencesMedicineMedical specialtyInternal medicineOncology
spellingShingle Xin Zhang
Licheng Wei
Jiangguo Li
Yuexia Deng
Wei Xu
Dongkui Chen
Xing Li
Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis
iScience
Health sciences
Medicine
Medical specialty
Internal medicine
Oncology
title Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis
title_full Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis
title_fullStr Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis
title_full_unstemmed Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis
title_short Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis
title_sort influence of myosteatosis on survival of patients with pancreatic cancer a systematic review and meta analysis
topic Health sciences
Medicine
Medical specialty
Internal medicine
Oncology
url http://www.sciencedirect.com/science/article/pii/S2589004224025689
work_keys_str_mv AT xinzhang influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis
AT lichengwei influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis
AT jiangguoli influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis
AT yuexiadeng influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis
AT weixu influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis
AT dongkuichen influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis
AT xingli influenceofmyosteatosisonsurvivalofpatientswithpancreaticcancerasystematicreviewandmetaanalysis